By SIMON CONSTABLE
Biotech company Gilead Sciences (GILD) will team up with Danish healthcare company Novo Nordisk (NVO) in their efforts to help combat liver disease.
The two companies said they will collaborate on clinical trials for medications for treating nonalcoholic steatohepatitis (NASH). Read more here.
Biotech company Gilead Sciences (GILD) will team up with Danish healthcare company Novo Nordisk (NVO) in their efforts to help combat liver disease.
The two companies said they will collaborate on clinical trials for medications for treating nonalcoholic steatohepatitis (NASH). Read more here.
No comments:
Post a Comment